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Abstract
Background: In addition to helminthic infections, elevated serum IgE levels were observed in many protozoal infections,
while their contribution during immune response to these pathogens remained unclear. As IgE/antigen immune complexes
(IgE-IC) bind to human cells through FceRI or FceRII/CD23 surface molecules, the present study aimed to identify which
functional receptor may be involved in IgE-IC interaction with human macrophages, the major effector cell during parasite
infection.
Methodology/Principal Findings: Human monocyte-derived macrophages were infected with Toxoplasma gondii before
being incubated with IgE-IC. IgE receptors were then identified using appropriate blocking antibodies. The activation of
cells and parasiticidal activity were evaluated by mediator quantification and direct counting of infected macrophages.
RNAs were extracted and cell supernatants were also collected for their content in tumor necrosis factor (TNF)-a, interleukin-
10 (IL-10) and nitrites. Sera from symptomatic infected patients were also tested for their content of IgE, IL-10 and nitrites,
and compared to values found in healthy donors. Results showed that IgE-IC induced intracellular elimination of parasites
by human macrophages. IgE-mediated effect was FceRI-independent, but required cross-linking of surface FceRII/CD23, cell
activation and the generation of nitric oxide (NO). Although TNF-a was shown to be produced during cell activation, this
cytokine had minor contribution in this phenomenon while endogenous and exogenous IL-10 down-regulated parasite
killing. Inverse relationship was found between IL-10 and NO expression by infected human macrophages at both mRNA
and mediator levels. The relationship between these in vitro data and in vivo levels of various factors in T. gondii infected
patients supports the involvement of CD23 antigen and IL-10 expression in disease control.
Conclusion: Thus, IgE may be considered as immune mediator during antiprotozoal activity of human macrophages
through its ability to trigger CD23 signaling. Increased cell activation by IgE-IC may also account for chronic inflammatory
diseases observed in some patients.
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Introduction
Beside its critical role in allergy, IgE is generally believed to play
a physiological role in immunity towards helminthic parasites [1].
Thus, in vivo expression of IgE has been observed during protozoal
infections such as those caused by Plasmodium spp. [2,3], Leishmania
spp. [4] and Trypanosoma cruzi [5], although the role of this
immunoglobulin in anti-microbial immunity remains unclear [6].
IgE/antigen bound to human cells through FceRI and FceRII
surface molecules [7]. Macrophages, which are pivotal effectors for
control of intracellular and extracellular parasites, fail to express
FceRI but may bound IgE through surface FceRII/CD23 antigen
[8–10,11]. CD23 is distinguished structurally from almost all other
immunoglobulin receptors as it belongs to the C-type (calcium-
dependent) lectin superfamily [7]. It has been previously identified
as a low affinity receptor for IgE on the surface of B lymphocytes,
monocytes, follicular dendritic cells, Langerhans cells, eosinophils,
epithelial cells and platelets. CD23 exhibits two isoforms, namely
CD23a and CD23b, which are differentially expressed. CD23a is
expressed by antigen-activated B cells before differentiation into
antibody-secreting plasma cells, whereas CD23b expression by
macrophages, B cells and a variety of inflammatory cells including
epithelial cells is induced during immune response [7]. Moreover,
expression of multimeric CD23b on the surface of various immune
cells dramatically increased its ligand affinity [7,12]. Consequent-
ly, CD23 plays a critical role during immune response including
IgE synthesis, B- and T-cell differentiation, and the secretion of
inflammatory mediators by various human cells [7]. Cross-linking
of surface CD23 promotes the generation of IL-1, IL-6, TNF-a,
H2O2 and iNOS-mediated NO through NFkB- and AP-1-
dependent mechanisms [8,13,14]. As both IFN-c and IL-4
promote surface CD23b expression in human macrophages, we
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Th2 immune responses [7,8,13]. In addition, soluble CD23
fragments, detected in human sera, mediate cell activation through
the ligation of surface CD11b/c on macrophages [15], or CD21
on lymphocytes [16]. The role of CD23 during intracellular killing
of intracellular Leishmania parasites [8] and mycobacteria [10] by
human macrophages has been shown in vitro and was found to be
mediated by NO.
To date, the exact role of CD23 during IgE-mediated immunity
remains unclear. We recently showed that blocking CD23 by
peptidic counter-structure abrogated IgE/antigen binding to
human macrophages while the blocking of FceRI had no effect
on these cells [17]. In the present work, we used T. gondii to
analyze the role of IgE during antiprotozoal activity of infected
normal human macrophages. This opportunistic intracellular
protozoan infects human macrophages and triggers Th1 and
Th2 cytokines that enables host survival and long-term parasite
persistence. Cytokine levels must be tightly balanced during this
response, because their overproduction may cause immunopa-
thology and host death [18,19]. This phenomenon has been
previously demonstrated in T. gondii infection of IL-10 knockout
mice that succumb because of their inability to down-regulate
parasite-induced proinflammatory cytokine production [20]. Th1-
dependent IFN-c production is a hallmark of effector immune
response to acute infection with most intra-macrophagic parasites,
including T. gondii [18,21]. IFN-c mediates the induction of the
tryptophan-catabolising enzyme indoleamine 2,3-dioxygenase, as
well as inducible nitric oxide synthase (iNOS), both known for
their role in the defense against pathogens and inflammation [21].
Although NO was shown to be required for protection against
intracellular T. gondii, the exact mechanism of iNOS promotion in
human infected macrophages by IFN-c is yet to be fully
understood [22,23]. Generation of NO through iNOS may also
be achieved following cross-linking of surface FceRII/CD23 in
human and rat macrophages [8,13]. Even if expressed by most
macrophages, the role of CD23 as functional IgE receptor on these
cells, together with its involvement during T. gondii infection
remained unknown. Using infected normal human macrophages,
we have analyzed the role of IgE and endogenous cytokines in the
anti-parasitic activity of these cells. Our study has implications for
the understanding of the biology of IgE during parasitic infection
since it mediates CD23-cross-linking, NO generation, parasite
killing and the down regulation of IL-10 levels produced by
infected cells. These data corroborated the reported levels of
cytokines during human infection and revealed a new mechanism
of macrophage antimicrobial activity.
Results
IgE mediates intracellular elimination of parasites by
human macrophages: Role of FceRII/CD23
Following contact with microbial antigens or their infection,
macrophages acquired increased levels of surface CD23 [8], but
the phenomenon was potentiated by IFN-c or IL-4 at transcrip-
tional level [24]. Following incubation with T. gondii, 54–72% of
macrophages were infected and increased expression of CD23 was
observed on their membrane (21–41% or 67–79% at 24 h and 48
post-infection respectively). Following 72 h incubation in medium
alone, the percentage of infected cells was slightly modified (from
55% to 60%). In vitro death of a small percentage of infected cells
could not be excluded. Addition of IgE-IC dramatically reduced
the number of infected macrophages (p,0.0002, Figure 1, upper
panel) and may be mimicked following the addition of cross-
linking anti-CD23 McAb to these cultures (From 57% to 4%
infected cells 72 h later). Combining both ligands resulted in a
complete clearance of parasites (,2% infected cells remained),
while cross-linking anti-FceRI has no effect in this respect,
supporting the role of CD23/FceRII in IgE-mediated toxoplas-
macidal activity. Of interest, pretreatment of infected cells with
IFN-c or IL-4, which increase CD23 surface expression in human
macrophages, had additive effect to their parasiticidal activity
(Figure 1). We also observed parasite killing with cells incubated
with IFN-c or IL-4 alone. This may likely be due, in part, to CD23
induction because simultaneous addition of anti-CD23-Fab
fragments, which blocks FceRII and prevents its cross-linking,
significantly (p,0.004) reversed parasite clearance (Figure 1,
middle panel). As simultaneous addition of IL-4 to CD23 ligands
resulted in better elimination of T. gondii by human macrophages,
we maintained these culture conditions for subsequent experi-
ments. Finally, we asked if IgE-mediated activation could prevent
macrophage infection with T. gondii. The cells were then treated
48 h with IgE-IC or anti-CD23 McAb before being incubated
with parasites and the results clearly indicate that parasites fail to
survive cell activation (Figure 1, lower panel). Microscopical
analysis indicated that most parasites were killed following
intracellular entry, although a small number of killed parasites
were also detected on cell membrane (data not shown).
Figure 1. IgE-IC induces toxoplasmacidal activity of human
macrophages through FceRII/CD23 ligation. T. gondii-infected
macrophages were incubated in the presence of IgE-IC, cross-linking
anti-FceRI (20 mg/ml), or anti-FceRII (10, 20 mg/ml) McAb and the
percentage of infected cells was assessed following 72 h incubation.
Only IgE-IC and anti-FceRII induced parasite elimination (upper panel).
Infected cell incubation with recombinant IL-4 or IFN-c induced parasite
killing, reversed by the simultaneous blockade of CD23 cross-linking by
Fab fragments of anti-CD23 McAb (20 mg/ml) (median panel). Cells were
also treated 24 h with IL-4 and IgE-IC or anti-CD23 prior to cell infection.
The lower panel shows that pretreatment of macrophages during 24 h
with CD23 ligands enabled them to resist to T. gondii infection. Results
show mean6SD from 3 distinct macrophage preparations, each done in
duplicates. Asterisks show significance compared to infected cells
cultured in medium alone.
doi:10.1371/journal.pone.0018289.g001
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T. gondii killing by human macrophages
The observed antimicrobial activity could be a direct conse-
quence of CD23 engagement or, alternatively, could be induced
by mediators generated by this pathway. Indeed, cross-linking of
CD23 on human macrophages is known to mediate cell activation
and the transcription of genes encoding various inflammatory
cytokines including TNF-a, IL-1, IL-6 or IL-8 [25]. CD23
pathway also promotes the generation of superoxide, the
transcription of iNOS gene and subsequent production of NO
by human macrophages [8], eosinophils [26], and epithelial cells
[27]. As NO mediates parasiticidal activity, we asked if CD23/NO
pathway had a role in T. gondii killing by human macrophages. For
this purpose, the amounts of nitrites, final metabolites of NO, were
quantified in cell supernatants. As shown in Figure 2A, data
indicate that FceRII/CD23 stimulation induced the expression of
iNOS mRNA. This finding was confirmed by the generation of
nitrites in cell supernatants. Figure 2B further shows that the
addition of the NOS inhibitor, N
G-monomethyl-L-arginine (L-
NMMA) significantly reversed parasiticidal activity (p,0.001)
while D-NMMA had no effect. Addition of L-arginine to L-
NMMA reversed NOS inhibition and restored parasite killing.
CD23-mediated effect in inducing parasite killing may be
mimicked by incubating infected cells with NO-releasing chemical,
s-nitroso acethylpenicillamine (SNAP, Figure 2B). These data
clearly support the role of NO during IgE-IC-mediated parasit-
icidal effect.
TNF-a generation by CD23-stimulated human
macrophages is not involved in T. gondii killing
We then investigated the role of TNF-a during IgE-IC-
mediated T. gondii killing because this cytokine has been suggested
as an toxoplasmacidal mediator [18,19]. Following CD23
activation, significant increase in TNF-a mRNA level was
observed in CD23-activated cells, compared to controls
(Figure 3A). Moreover, we observed reversion of this phenomenon
by genistein, an inhibitor of protein tyrosine kinase (PTK) activity
[28], a critical intracellular signal transduction pathway during
CD23-mediated cell activation [29]. CD23 also led to increased
production of TNF-a in cell supernatants (from 42624 to
Figure 2. Involvement of iNOS pathway during IgE-IC-mediat-
ed activation of T. gondii killing by human macrophages.
Infected cells were incubated in the presence of IL-4, IgE-IC or anti-CD23
McAb. (A) Cells were then collected (24 h) for iNOS-mRNA quantifica-
tion and cell supernatants were harvested (72 h) to assess the levels of
nitrites. Both conditions induced iNOS mRNA expression and conse-
quent NO generation. (B) Cells were also incubated with an iNOS
inhibitor (L-NMMA), a negative control (D-NMMA), or chemical NO-
donor (SNAP). Following 72 h incubation, the percentage of infected
macrophages was assessed. Addition of L-NMMA inhibited IgE-IC- or
CD23-mediated parasiticidal activity (p,0.0008) and was reversed by L-
arginine supplementation. Addition of chemical NO completely
destroyed parasites without cell toxicity (.75% viable cells found in
control cultures). Results show mean6SD for data from 3 distinct
macrophage preparations, each done in duplicates.
doi:10.1371/journal.pone.0018289.g002
Figure 3. Minor role for CD23-induced TNF-a during activation
of parasiticidal activity of human macrophages. (A)C D 2 3
engagement induces TNF-a gene expression in human macrophages
through tyrosine kinase-sensitive pathway. Data from one donor was
shown, out of two. (B) Recombinant TNF-a (100 IU/ml) induced low but
significant elimination (p,0.007) of parasites in infected cells while anti-
TNF-a McAb (20 mg/ml) had limited effect on CD23-mediated
parasiticidal activity of human macrophages. Results show mean6SD
from three distinct MDM preparations following 72 h incubation, each
done in duplicates.
doi:10.1371/journal.pone.0018289.g003
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preparations). In non-activated macrophages, exogenous recom-
binant TNF-a induced low but significant parasite killing
(p,0.008, Figure 3B), while simultaneous addition of neutralizing
anti-TNF-a antibody during CD23 activation did not significantly
reduce parasite clearance (p=0.09). This result suggested little or
no involvement of this cytokine during CD23 engagement.
IL-10 decreased IgE-mediated T. gondii killing by human
macrophage
The regulation of toxoplasmacidal effects of CD23 pathway was
investigated. We have previously shown that IL-10, a Th2
cytokine produced during various inflammatory responses,
down-regulated CD23/NO pathway in human cells [10,24,30].
In addition, T. gondii infection was previously shown to induce IL-
10 production in vivo and this cytokine may therefore moderate
the inflammatory response of macrophages [31]. We here show
that the addition of recombinant IL-10 during CD23 engage-
ment reduced parasite killing and NO generation from infected
human macrophages (Figure 4A). Of interest, addition of
neutralizing anti-IL-10 to macrophages resulted in a significant
reduction of infected cell number and increased NO generation by
these cells, even in the absence of exogenous stimulation
(Figure 4A). This suggested that autologous IL-10 may be induced
following cell infection. To confirm this observation, we quantified
IL-10 levels in MDM supernatants following their infection
with T. gondii. A time-dependent increase of IL-10 levels in human
MDM supernatants was observed (Figure 4B). Data from
Figure 4C further indicates that T. gondii induced IL-10 expression
at both mRNA and protein levels and that IL-10 expression
Figure 4. Inhibition of IgE-IC-mediated toxoplasmacidal activity of human macrophages by endogenous and exogenous IL-10. (A)
Simultaneous addition of recombinant IL-10 (10 ng/ml) to CD23-engaged macrophages significantly decreased their ability to eliminate T. gondii.
Addition of neutralizing anti-IL-10 (20 mg/ml) McAb increased cell resistance to infection in the absence of CD23 engagement. Results show
mean6SD from 3 distinct MDM preparations following 72 h incubation, each done in duplicates. (B) Infection with T. gondii induces IL-10 generation
by human macrophages. Results show mean6SD from two distinct MDM preparations, each done in duplicates. (C) Infected or uninfected cells were
incubated with anti-CD23 or chemical NO (SNAP) and were collected 24 h later for iNOS- and IL-10-mRNA quantification and cell supernatants were
harvested (72 h) to assess the levels of nitrites and IL-10. CD23 engagement reduced T. gondii-mediated IL-10 increase at both mRNA and protein
levels and was inversely correlated with iNOS expression by infected human macrophages. Chemical NO (SNAP) also reduced the IL-10 expression
from infected macrophages. Results show mRNA quantification from one representative macrophage preparation, out of two and mean6SD from 2
distinct MDM preparations following 72 h incubation for the quantification of mediators, each done in duplicates.
doi:10.1371/journal.pone.0018289.g004
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Of particular interest, while CD23-mediated activation of
uninfected macrophages induced low IL-10 levels (Figure 4C),
CD23 stimulation or chemical NO decreased IL-10 expression in
human T.gondii-infected macrophages at both RNA and protein
levels.
In vivo expression of IL-10, NO derivatives and IgE in
patients’ sera
In vitro data lead us to investigate the in vivo presence of various
above inflammatory mediators described in sera from T. gondii-
infected patients compared to non infected controls. Sera from
infected patients and uninfected donors were tested for their IL-10,
IgE and nitrites/nitrates content. Data in Figure 5A clearly shows
significantly higher levels of IL-10 in sera from infected
symptomatic patients versus uninfected controls. Figure 5B also
indicates that sera from T. gondii-infected donors contained
significantly elevated IgE levels compared to controls (p,0.004),
while the levels of nitrites were variable and mostly closed to those
from uninfected controls.
Discussion
Immune response to parasite infection is often correlated with
an increased expression of IgE in mammals, which is believed to
play a protective role against worms [1]. Meanwhile, the role of
IgE and its receptors during antiprotozoal immune response still
remains to be fully understood. Our study clearly shows that
macrophages, in the absence of FceRI, express FceRII at enough
surface levels that enable them to cross-link these receptors by IgE-
IC or other physiologic ligands. Consistently, CD23 expression
following infection with T. gondii parasites may be due to their
ability to induce the transcription factor STAT6 [11], which is
involved in the induction of Th-2 gene promotion including
CD40, CD23 and IgE. Furthermore, maternal immunity to T.
gondii has been associated with specific IgE detection in cord blood
[32]. Parasite antigens may also activate p38 mitogen-activated
protein kinase P [33], which has been reported to mediate IL-4-
induced expression of CD23 [29]. Cytokines from infected or
neighboring cells are important in macrophage activation, CD23
expression and the generation of parasiticidal agents. Therefore,
the balance of in situ cytokines such as TNF-a, IL-12, IL-10, IL-4
and IFN-c has the dual effect of keeping the host alive and/or
inducing inflammatory disease when overproduced. Our data
suggest that following T. gondii infection, macrophages acquire
simultaneously CD23 signaling and the availability of IgE-IC,
their natural ligands. Previous studies conducted in various
parasitic and microbial infections have shown CD23 expression
together with its role in intracellular and extracellular killing of
pathogens by macrophages [3,8,10]. Cell activation via CD23
requires the presence of appropriate physiologic ligands [25] such
as immunoglobulin E, CD21, CD11b/c, CD47-vitronectin, and
mannose-containing proteins [7]. In our study, CD23-crosslinking
by IgE/anti-IgE or anti-CD23-McAb was shown to mediate
parasite killing in human macrophages. This finding supports the
role of CD23 as a functional IgE receptor in these cells. This was
further confirmed through the ability of Fab fragments of anti-
CD23 McAb, which bind CD23 without cross-linkage, to block
cell activation and reversed the antimicrobial effect. CD23
pathway also account for IFN-c- and IL-4-mediated parasiticidal
activities as both cytokines were found to be less efficient following
CD23 blockade with anti-CD23 Fab fragments. Moreover, both
cytokines were well known for their ability to increase surface
CD23 expression on human macrophages. Therefore, the
acquisition of surface CD23 and the availability of its physiological
ligands in cell environment may argue for its important role in
human immune response to T. gondii infection.
CD23-mediated NO generation seems to play a major role during
parasiticidal activity of macrophages. NO. is a highly reactive and
diffusible free radical, soluble in both lipids and water. It reacts with
oxygen and reactive oxygen intermediates forming NO2,N O 2
2,
NO3
2,N 2O3, and the highly parasiticidal ONOO
2 [34]. Inducible
nitric oxide synthase is the major generator of NO in MDM and is a
tightly regulated enzyme. Therefore, CD23 engagement, which
mediates increased transcription of iNOS in human macrophages,
induces NO generation following T. gondii infection. Furthermore, in
murine macrophages, parasites may escape this pathway through
their ability to decrease iNOS expression by infected cells via an
unknown mechanism [35]. One plausible hypothesis may be related
to their ability to generate Toll-like receptor-induced arginase 1 in
macrophages which may act in reducing the intracellular arginine
level, the latter being necessary for an optimal iNOS function [35].
Indeed, dominated T helper type 2 responses in parasitic disease
increased arginase expression by IL - 4a n dI L - 1 3s i g n a l i n gt h r o u g h
the transcription factor STAT6 [36].
Figure 5. The presence of IL-10, IgE and nitrites in sera from
patients infected with T. gondii. Freshly isolated sera from 18 T.
gondii infected patients or 11–18 uninfected controls were tested for
the levels of IL-10, IgE and nitrites. (A) Infected patients have
significantly high serum levels of IL-10 compared to controls.
(B) Elevated IgE levels were detected in infected patients compared
to controls, while concentrations of serum nitrites were close to normal
values except to 6/8 patients with high IgE (.200 IU) levels (p,0.018).
doi:10.1371/journal.pone.0018289.g005
IgE Mediates T. gondii Killing by Macrophages
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18289Among cytokines, TNF-a plays a critical role in host defense
against intracellular parasite infections [18]. CD23 engagement is
responsible for a significant increase in TNF-a secretion by MDM.
However, the addition of anti-TNF-a during CD23 activation has
little or no impact on the microbiocidal activity, suggesting a
minor role for this cytokine in this system. In this context, it is
striking to note that TNF-a was previously shown to be necessary
for an optimal NO production from human infected macrophages
[8,37]. By contrast, CD23 pathway differs from Toll-like receptor
mediated toxoplasmacidal activity, where a critical role for TNF-a
[38] while NO seems to play a marginal role [39].
Like other inflammatory mediators, IL-10 is produced following
CD23-mediated activation of normal uninfected macrophages
[17,30]. The levels of IL-10 inversely correlate with the generation
of other inflammatory mediators, including NO [10,24,30]. These
data corroborate studies conducted in IL-10
2/2 mice that have
observed lethal or exacerbated inflammatory disease following
Toxoplasma infection [20]. Accordingly, in vitro infection of human
macrophage with T. gondii resulted in an increased expression of
IL-10 from these cells, which inversely correlated with iNOS
expression and NO generation. In contrast to uninfected cells,
CD23-activation of T. gondii-infected macrophages had no additive
effect on IL-10 production but rather down regulated this cytokine
(Figure 4C). This clearly evidenced T. gondii strategy to escape
human immune response as incubation of infected macrophages
with neutralizing anti-IL-10 antibody led to increased elimination
of parasites without additional in vitro activation. These in vitro data
corroborate in vivo observations as we clearly ascertained that acute
T. gondii infected patients had increased IgE and IL-10 levels in
their sera, while NO levels were close to normal controls.
Imunoregulation by T. gondii infection also prevents allergic
immune reponses and IgE production in mice [40]. Together,
our findings clearly demonstrate the role of IgE-IC in mediating
intracellular protozoal elimination through their ability to ligate
membrane bound CD23/FceRII. Moreover, the latter evidence
supports the mechanism leading to the frequently reported
increase of peripheral IgE levels that occur in the course of these
infections. IgE-dependent immune response and protozoal
elimination also raise the question of the possible interaction with
nematode infections and disease outcome [41,42]. Finally, high
levels of TNF-a and NO mediated through IgE generation may
also account for deleterious chronic inflammatory diseases that are
observed during many parasitic infections.
Materials and Methods
Ethics statement
Informed written consent was given by the blood volunteer
donors and the study was approved and strictly followed the ethics
guidelines of Medical Ethical Committees at the University of
Pierre et Marie Curie, Paris, France, and conducted under full
compliance with government policies and the Helsinki Declara-
tion. Patients’ data were obtained from routine investigations or
provided from blood samples beyond the procedures aimed for
diagnosis or management of patients and strictly followed the
ethics guidelines of local Medical Ethical Committees (see above).
Parasite cultures
Toxoplasma gondii (T. gondii). Virulent RH strain was maintained
in Balb/c mice (Iffa-Credo, St German/Arbresle, France) by
intraperitoneal passage and isolated by peritoneal lavage following
filtration. Tachyzoites were used in our study and their viability
controlled by trypan blue dye exclusion and only parasite
preparations with .95% viable cells were used. All animal
procedures were performed in strict accordance with the
guidelines issued by the European Economic Community ‘‘86/
609’’ and local authority approval (Prefecture de la Gironde Nu
33/03239).
Human cells and infection
Peripheral blood samples pre-tested for the absence of HIV or
hepatitis B and C virus infection were obtained from healthy
volunteers (Blood Transfusion Center, Pitie ´-Salpe ˆtrie `re Hospital,
Paris, France). Peripheral blood-derived mononuclear leukocytes
were obtained by Ficoll gradient separation and suspended in
McCoy 5A modified culture media supplemented with 100 U/ml
penicillin, 100 mg/ml streptomycin, 25 mM HEPES, 0.1 mM 2-
mercaptoethanol, 2 mM sodium pyruvate, 0.2 mM L-cysteine,
5 mg/ml polymyxin B and 10% fetal calf serum (FCS) (all from
Invitrogen, Paisley, UK). All the above culture medium,
chemicals, and FCS were endotoxin-free and tested for the
absence of direct activation effect on human monocytes (CD23
expression and TNF-a production as activation markers).
Monocytes were subsequently separated from other leukocytes
by adherence to FCS-coated culture flasks and re-incubated for
additional five days in the same culture conditions. Following these
procedures, .95% of cells expressed CD14 antigen and displayed
cytochemical characteristics of monocyte-derived macrophages
(MDM) [8]. Cells were collected and re-incubated (2,5610
6/ml) in
Lab-tek culture ‘‘chambers’’ during 60 min in the presence of T.
gondii tachyzoites at 1:2 cell:parasites ratio in DMEM complete
medium at 37uC in humidified air, containing 5% CO2. They
were washed and re-incubated for additional 24 h at 2610
5
MDM/ml before being treated with various molecules. This led to
the infection of 57–73% MDM as counted by direct microscopical
analysis of May-Grunwald Giemsa (MGG)-stained cytospin
preparations. For each culture condition, 500 MDM were
examined in two separate experiments. To measure MDM
viability and apoptosis, externalization of membrane phosphati-
dylserine was analyzed using annexin V-FITC and propidium
iodide kit (Immunotech, Marseille, France). The percentage of
apoptotic/infected cells was obtained following count of 200 cells
in each well under fluorescence microscopy. Concurrently, serum
levels of IgE, nitrites and IL-10 were analyzed from samples
collected beyond routine exploration of HIV-free patients with
symptomatic primary T. gondii infection. Values were compared to
those found in sera from normal healthy T. gondii infection-free
donors.
Human cell activation
Cell surface expression of CD23 and CD14 was measured by
flow cytometry, using FITC-labeled McAbs (Beckman-Coulter,
Fullerton, CA, USA). Infected MDM were directly activated
through CD23 pathway while CD23 cell surface expression was
induced in uninfected MDM in the presence of recombinant
human IFN-c (100 IU/ml, Clinisciences, Montrouge, France) or
IL-4 (10 ng/ml, gift from Novartis, Basel, Switzerland) as
described elsewhere [8,24]. CD23-positive cells were incubated
in the presence of human IgE/anti-IgE (10 mg/ml of each, Nordic,
Tilburg, Netherlands) immune complexes or cross-linking anti-
CD23 monoclonal antibody (CD23-MAb, clone 135, IgG1k,
20 mg/ml, Novartis, Basel, Switzerland) or anti-FceRI (clone 15-1)
as detailed elsewhere [9]. MDM cultures were supplemented with
the chemical NO donor, SNAP (S-Nitroso-N-acetylpenicillamine;
Coger, Paris, France), recombinant human IL-10 or TNF-a,
neutralizing anti-human-TNF-a (Genzyme, Cambridge, MA,
USA), neutralizing anti-human IL-10 McAb, isotype-matched
IgE Mediates T. gondii Killing by Macrophages
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or genistein (Sigma-Aldrich, St Quantin Fallavier, France).
RNA preparations and detection
Following cultures, total cell RNA was extracted using RNeasy
kit (Qiagen, Hilden, Germany). Reverse transcription-PCR was
performed with an automatic thermal cycler (iCycler, Biorad)
using the following specific primers: iNOS mRNA sense (59-
ATGCCAGATGGCAGCATCAGA-39, exon 8) and iNOS
mRNA antisense (59-ACTTCCTCCAGGATGTTGTA-39, exon
11). IL-10 mRNA sense, 59-GCAACCTGCCTAACATGC-
TTCG-39; IL-10 mRNA antisense, 59-GAAGATGTCAAACT-
CACTCA TGGC-39 (exon 11). Hypoxanthine phosphoribosyl-
transferase (HPRT) mRNA sense (59TATGGACAGGACT-
GAACGTCTTGC-39) and HPRT mRNA antisense (59-GAC-
ACAAACATGATTCAAATCCCTGA-39) primers were used as
controls. The iNOS messenger is represented by a 371-bp band,
IL-10 by 388-bp band, whereas a 496-bp band indicates the
HPRT messenger. Signal intensity was compared to HPRT
control AlphaImager HP automatic image capture software
(Alpha-Innotec, San Leandro, CA, USA). Ten mg of total RNA
was analyzed by Northern blot hybridization as described for the
expression of TNF-a mRNA using 32P-labeled probe [43], a 685-
bp BgI-Pst I fragment of pE4 (American Type Culture Collection,
Rockville, MD, USA), compared to a 1.1-kb Pst I bActin (a gift
from D. Stehelin, Institut Pasteur, Lille, France).
Analysis of NO, IgE and cytokine quantification
Culture supernatants (48–72 h) or sera were tested for the stable
end-product of NO, NO2
2 using the Griess reaction modified as
detailed elsewhere [44]. This method gave a sensitivity limit of
0.2 mM if low NO2
2 medium (DMEM) was used. TNF-a and IL-
10 (Bender Medsystems, Vienna, Austria) and total human IgE
(Mabtech AB, Sophia Antipolis, France) were quantified using
specific ELISA kits.
Statistical analysis
Comparisons of data from infected patients were assessed using
Fischer’s exact test for proportions and Mann-Whitney U test for
quantitative values. Results from in vitro cultures were analyzed
and compared using the Student t-test for paired data. P,0.05 was
considered to be significant.
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